Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

100
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
100
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

246
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
246
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

51
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
51
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

45
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

76
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential transcatheter closure of sinus venosus and secundum atrial septal defects using covered stents and a septal occluder, a two-step strategy: a case report.

Journal of medical case reports·2026
Same author

A Stepwise Approach to Coronary Bifurcation Stenting: Enhancing Safety and Efficacy With Modified Jailed Balloon Techniques.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Conservative management of iatrogenic pulmonary vein obstruction following transcatheter sinus venosus ASD repair: a case insight and literature review.

BMC cardiovascular disorders·2026
Same author

Transcatheter Closure of Paravalvular Leaks: Efficacy, Techniques, and Outcomes From a Single-Center Prospective Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Transhepatic Access for Transcatheter ASD Closure in Patients With Interrupted IVC.

JACC. Case reports·2026
Same author

Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study.

EClinicalMedicine·2026

Related Experiment Video

Updated: Oct 5, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Cardiac solution for a vascular scenario!

Jamal Moosavi1, Somaye Ahmadi2, Ata Firouzi1

  • 1Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

CVIR Endovascular
|February 1, 2022
PubMed
Summary
This summary is machine-generated.

Ascending aortic pseudoaneurysms (AAPs) after surgery can be treated with a transcatheter approach. A percutaneous closure using an Amplatzer Atrial Septal Defect Occluder (ASO) device is a viable alternative to surgery.

Keywords:
ASO deviceAmplatzer atrial septal defect Occluder deviceAortic cannulation siteTranscatheter closure of ascending aorta pseudoaneurysm

More Related Videos

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

11.8K
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.9K

Related Experiment Videos

Last Updated: Oct 5, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

11.8K
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.9K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Devices

Background:

  • Ascending aortic pseudoaneurysms (AAPs) are rare but serious complications, occurring in up to 13% of patients post-cardiac or aortic surgery.
  • Repeat thoracotomy in patients with prior cardiac surgery carries significant risks.
  • High morbidity and mortality associated with traditional surgical management necessitate alternative approaches.

Purpose of the Study:

  • To describe a novel transcatheter approach for treating ascending aortic pseudoaneurysms.
  • To evaluate the efficacy of percutaneous closure using an Amplatzer Atrial Septal Defect Occluder (ASO) device.

Main Methods:

  • Case report of a 65-year-old male patient post-coronary artery bypass grafting (CABG).
  • Percutaneous closure of an AAP at the aortic cannulation site was performed.
  • An Amplatzer Atrial Septal Defect Occluder (ASO) device was utilized for the closure.

Main Results:

  • Successful percutaneous closure of the ascending aortic pseudoaneurysm was achieved.
  • The patient tolerated the procedure well, avoiding open-heart surgery.

Conclusions:

  • Transcatheter closure of ascending aortic pseudoaneurysms is feasible.
  • The Amplatzer Atrial Septal Defect Occluder (ASO) device offers an acceptable alternative to surgical intervention for AAPs.